Corton Capital Inc. Immuneering Corp Transaction History

Corton Capital Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.91 - $7.32 $800 - $3,067	-419 Reduced 1.55%	26,536 $76,000
Q4 2023 Feb 14, 2024	BUY	$4.84 - $8.44 $39,242 - $68,431	8,108 Added 43.02%	26,955 $198,000
Q3 2023 Nov 14, 2023	BUY	$7.21 - $10.68 $135,886 - $201,285	18,847 New	18,847 $144,000

9.65M

Ticker IMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,392,300
Market Cap $70.2M
Description
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Corton Capital Inc. with notifications on news.